BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 77579)

  • 1. The diagnostic value of serum copper levels and other hematochemical parameters in malignancies.
    Pizzolo G; Savarin T; Molino AM; Ambrosetti A; Todeschini G; Vettore L
    Tumori; 1978 Feb; 64(1):55-61. PubMed ID: 77579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of metabolic parameters in Hodgkin's disease (author's transl)].
    Oertel J; Gerhartz H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Jun; 86(2):185-93. PubMed ID: 59479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHANGES IN SERUM ALPHA-2 GLOBULINS IN RETICULOSES.
    MALPAS JS; FAIRLEY GH
    J Clin Pathol; 1964 Nov; 17(6):651-4. PubMed ID: 14227435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ferritin levels in hematologic malignant neoplasms.
    Patel AR; Shah PC; Vohra RM; Hart WL; Shah JR
    Arch Pathol Lab Med; 1980 Oct; 104(10):509-12. PubMed ID: 6932189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ferritin in hematologic malignancies.
    Matzner Y; Konijn AM; Hershko C
    Am J Hematol; 1980; 9(1):13-22. PubMed ID: 7001894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease].
    Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R
    Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445
    [No Abstract]   [Full Text] [Related]  

  • 10. [HL-A antigens and malignant hematological diseases].
    Jeannet M; Alberto P; Wyss M
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1798-800. PubMed ID: 5291103
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
    Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
    Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-2-microglobulin review: its relevance in clinical oncology.
    Cooper EH; Plesner T
    Med Pediatr Oncol; 1980; 8(4):323-34. PubMed ID: 6161299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophoretic abnormalities in chronic lymphocytic leukemia and cancer sera.
    Werthamer S; Amaral L
    Am J Clin Pathol; 1976 Jan; 65(1):40-8. PubMed ID: 55071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
    Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
    Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement in hematological neoplasias.
    Batlle Fonrodona FJ; López Fernández MF; Vicente García V; Corral Alonso M; López Borrasca A
    Allergol Immunopathol (Madr); 1979; 7(1):39-46. PubMed ID: 474324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Iron, copper and iron/copper index in the serum during remission of acute leukemia in children].
    Legutko L
    Acta Haematol Pol; 1978; 9(3):179-85. PubMed ID: 281085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative measurement and clinical analysis of serum levels of immunosuppressive acidic protein (IAP) in hematopoietic malignancies].
    Hamaguchi H; Karitani Y; Minami N; Tanaka I; Iwata Y; Shirakawa S
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1231-6. PubMed ID: 6732251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum alpha-1-acid-glycoprotein, haptoglobin and C3 in Hodgkin's disease. A comparison with other acute-phase indicators.
    Gobbi PG; Merlini G; Parrinello GA; Cavalli P; Ascari E
    Acta Haematol; 1982; 67(4):255-62. PubMed ID: 6180585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum vitamin B 12 and vitamin B 12 binding capacity in chronic myelogenous leukemia and other disorders.
    Rosner F; Schreiber ZA
    Am J Med Sci; 1972 Jun; 263(6):473-80. PubMed ID: 4505888
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beta 2 microglobulin].
    Clément F
    Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.